Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of DA-5207 Transdermal System in Healthy Adults
NCT04479865Phase 1Unknown
- Sponsor
- Dong-A ST
- Start
- Jul 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of donepezil transdermal patch in Alzheimer's disease (AD) (4 arms), sponsored by Dong-A ST. Primary endpoints: Area Under the Curve and Maximum Steady State Concentration. Status: unknown.
02
Drugs
donepezil transdermal patch
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT04479865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04479865.